GEMAROMA
1 call
Concalls & earnings callsGem Aromatics Limited
Every summarised call, newest first. Latest is Q1 FY27, held 14 Aug 2026.
Latest quarter
Q1 FY27 snapshot
Open full brief →A seasonally soft quarter was impacted by clove supply disruptions, while the focus remains on ramping up higher-margin specialty products at the new Dahej facility to drive future growth.
| Metric | This quarter | Change | Five-quarter trend |
|---|---|---|---|
| Revenue (Standalone) | ₹83 Cr | — | |
| Revenue (Consolidated) | ₹99 Cr | — | |
| Gross Profit (Standalone) | ₹14.7 Cr | — | |
| Gross Margin (Standalone) | 17.7% | — |
Latest guidance
- Cooling agents: meaningful revenue contribution expected from Q3 FY27.
- Safranal: revenue contribution expected towards end of Q2 FY27, more meaningful from Q3 FY27.
- Phenol derivatives: commercial production targeted during Q3 FY27, meaningful revenue contribution expected from Q4 FY27.
- FY27 is a ramp-up year for new product verticals; meaningful ramp-up and significant volumes expected in FY28.
- Krystal products expected to be more than 50% of overall revenue by FY28.
Said on the Q1 FY27 call.
Call history
- Q1 FY27Cautious tone
A seasonally soft quarter was impacted by clove supply disruptions, while the focus remains on ramping up higher-margin specialty products at the new Dahej facility to drive future growth.
- Revenue (Standalone)
- ₹83 Cr
- Revenue (Consolidated)
- ₹99 Cr